Articles On Avita Medical (ASX:AVH)

The Phoslock Environmental Technologies Ltd (ASX: PET) share price has now quadrupled in 2019 from 35 cents per share at the start of the year to $1.40 today. Based on 555.5 million shares on issue it now has a market value around $778 mil...

A lot of retail share market traders like to pile into whatever’s hot or going up fast in the small-cap sector as they’re more interested in price action than the merits of the underlying business. In turn the hot money can amplify the sha...

In light of the volatility that has rocked global equities markets including the ASX, Finfeed felt it was timely to assess the damage on a sector by sector basis. What’s more, we have come up with six stocks that appear to have plenty going...

AVITA Medical (ASX:AVH), an Australian-based global regenerative medicine company, will be added to the S&P/ASX 300 index from 23 September 2019.

In afternoon trade the S&P/ASX 200 index has followed the lead of U.S. markets and is on course to finish the week on a very positive note. At the time of writing the index is up by a sizeable 1.35% to 6,595.2 points. Four shares that...

The Avita Medical Ltd (ASX: AVH) share price has risen more than 500% since January. This may lead to some investors avoiding Avita Medical shares in fear of paying too much. However, even after this massive price rise, I believe the share...

Micro-encapsulation may sound like something that only matters for the highly scientifically-literate. But in a competitive market like infant formula it could make a big difference. Stockhead spoke with both sides of a deal completed last...

The micro or small-cap end of the share market is full of shares that will regularly move rapidly higher or lower in the space of just a few days as sentiment swings around the businesses and a lack of liquidity adds to the volatility.  It...

The following pharmaceutical sector companies have recently disclosed their June 2019 quarterly updates. Let us have a brief glance at how these companies faired in the recent three months. AVITA Medical Ltd AVITA Medical Ltd (ASX: AVH), a...

Since the ASX is flooded with quarterlies, we’ve summarised a list of the five health companies that got the biggest share-price boost in morning trade due to 4C releases: Oncosil Medical (ASX: OSL) As Oncosil is at the research and develop...

This week the Jumbo Interactive Ltd (ASX: JIN) share price continued its impressive run and hit a new all-time high of $20.65. When its shares reached this level, it meant the lottery ticket seller had gained a whopping 354% since this tim...

One of the best performers on the Australian share market on Tuesday has been the PuriflOH Ltd (ASX: PO3) share price. In afternoon trade the air and water treatment company’s shares are up over 17% to $3.72. This means the PuriflOH share...

A lot of debate has emerged recently over why growth shares have tended to outperform value shares with the low interest rate environment worldwide one obvious reason. As interest or risk free rates on cash or other risk free assets like U...

The Nearmap Ltd (ASX: NEA) share price is taking a beating for a second day following the release of its full year results update on Friday. The NEA share price fell 2.7% to $3.25 in morning trade when the S&P/ASX 200 (Index:^AXJO) (AS...

Even after yesterday’s disappointing decline, the All Ordinaries index is up 20% since the start of the year. Whilst this is an impressive gain, a number of shares on the index have outperformed it by a significant margin. Here’s why these...

NEA, AVH and XRO have provided positive returns for one month, three months and six month period, respectively. Moreover, in terms of long term perspective, all three stocks have exhibited robust returns for five years. Let’s have a look at...

Since the turn of the year the All Ordinaries index has been in fine form and generated a return of over 20%. Whilst this is very impressive, there are a number of shares on the index that have vastly outperformed it. Three shares that hav...

It has been a positive start to the new financial year for the S&P/ASX 200 index. In afternoon trade the benchmark index is 0.4% higher at 6,646.6 points. Four shares that have climbed more than most today are listed below. Here’s why...

The AVITA Medical Ltd (ASX: AVH) share price was one of the best performers on the local market during the last financial year. During the period the regenerative medicine company’s shares rose an incredible 500%. The good news for shareho...

Regenerative medicine company AVITA Medical (ASX: AVH) has published “favourable” results from an open-label feasibility study of its RECELL Autologous Cell Harvesting Device for the treatment of diabetic foot ulcers (DFUs). AVITA Medical h...

In this week's Weekly Insights (published in two parts):-Crucial Question: Is It 1995 or 2007?-Conviction Calls -Gold Stocks: Winners & Losers-Rudi On Tour -Rudi TalksConviction Calls By Rudi Filapek-Vandyck, Editor FNArena Stockb...

This week I took a look at the 10 best-performing large cap and mid cap shares so far in 2019. Out of the large caps only two had managed to double in 2019 including Magellan Financial Group Ltd (ASX: MFG) and Fortescue Metals Group Limite...

Since the start of the year the All Ordinaries index has risen an impressive ~17.5% excluding dividends. Whilst this is undoubtedly a strong gain, some constituents of the index have managed to vastly outperform it. Three shares that have...

The PolyNovo Ltd  (ASX: PNV) share price has been amongst the best-performers on the Australian share market over the last 12 months. On Monday the medical device company’s shares hit a multi-year high of $1.59, which stretched their 12-mon...

Avita Medical Ltd Strong Performance During the Third Quarter of 2019: Avita Medical Ltd (ASX: AVH) released its quarterly report for the period ended 31 March 2019 on 30 April 2019. The company mentioned that for the third quarter of 2019,...

AVITA Medical (ASX:AVH),  a regenerative medicine company with a technology platform designed to address unmet medical needs in therapeutic skin restoration, has announced new preliminary data relating to its RECELL Autologous Cell...